3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
14
fludarabine
8
Rituximab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Vincristine
4
Doxorubicin
4
Dexamethasone
4
zanubrutinib
3
Prednisone
3
Nivolumab
3
Etoposide
3
tazemetostat
2
tafasitamab
2
pirtobrutinib
2
pembrolizumab
2
glofitamab
2
etoposide phosphate
2
cemiplimab
2
acalabrutinib
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Cisplatin
2
Cell- and Tissue-Based Therapy
2
Biopsy
2
venetoclax
1
varlilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.